References
- Pegg A E, McCann P P. Polyamine metabolism and function. Am J Physiol 1982; 243: C212–C221
- Pegg A E. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986; 234: 249–262
- Tabor C W, Tabor H. Polyamines. Ann Rev Biochem 1984; 53: 749–790
- Heby O. Role of polyamines in the control of cell prcliferation and differentiation. Differentiation 1981; 19: 1–20
- Koenig H, Goldstein A, Lu C Y. Polyamines regulate calcium fluxes in a rapid plasma membrane response. Nature 1983; 305: 530–534
- Olson J W, Orlinska U, Gillespie M N. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity. Biochem Pharmacol 1989; 39: 2903–2910
- Ruskoaho H, Raunio H. Altered cardiac polyamine biosynthesis in spontaneously hypertensive rats. Am J Physiol 1987; 253: H262–H269
- Yamori Y, Igawa T, Tagami M, Kanbe T, Nara Y, Kihara M, Horie R. Humoral trophic influence on cardioavasculr structural changes in hypertension. Hypertension 1984; 6(Suppl III)III-27–111–32
- Leitschuh M, Hingorani V, Brecher P, Chobanian A V. Aortic ornithine decarboxylase activity in deoxycorticosterone/salt hypertensive rats. Life Sciences 1991; 48: 465–468
- Soltis E E, Newman P S, Olson J W. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension 1991; 18: 85–92
- Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347–504
- Mulvany M J. Structure and function of small arteries in hypertension. J. Hypertension 1990; 8(Suppl 7)S225–S232
- Mulvany M J. The development and regression of vascular hypertrophy. J Cardiovasc Pharmacol 1992; 19(Suppl 2)S22–S27
- Schiffrin E L. Reactivity of small blood vessels in hypertension: relation with structural changes. Hypertension 1992; 19(Suppl II)II-1–II-9
- van Breemen C, Cauvin C, Johns A, Leijten P, Yamamoto H. Ca2- regulation of vascular smooth muscle. Fed Proc 1986; 45: 2746–2751
- Boonen H CM, DeMey J GR. Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines. Eur J Pharmacol 1990; 179: 403–412
- El Mangiarua, Lee R MKW. Increased sympathetic innervation in the cerebral and mesenteric arteries of hypertensive rats. Can J Physiol Pharmacol 1990; 68: 492–499
- Cassis L, Stitzel R E, Head R J. Hyper-noradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: influence upon neuroeffector mechanisms. J Pharmacol Exp Therap 1985; 234: 792–803
- Brown M, Newman P, Trowbridge J, Rose B, Pass S, Feger A, Guo H, Olson J, Soltis E. Eflornithine (DFMO) treatment and vascular polyamines in established hypertension in the DOCA-salt rat. FASEB J 1993; 7: A548
- Gillespie M N, Dyer K K, Olson J W, O'Connor W N, Altiere R J. α-Difluoromethylornithine, an inhibitor of pclyamine synthesis, attenuates monocrotaline induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs. Res Commun Chem Pathol Pharmacol 1985; 50: 365–378
- Bartolome J V, Trepanier P A, Chait E A, Slotkin T A. Role of polyamines in isoproterenol-induced cardiac hypertrophy: effects of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. J Mol Cell Cardiol 1982; 14: 461–466
- Pedersen S B, Flyvbjerg A, Richelsen B. Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes. Am J Physiol 1993; 264: C453–C456
- Soltis E E, Newman P S, Brown M E, Trowbridge J L, Guo H, Arcot S, Olson J W. The vascular ornithine decarboxylase/polyamine system in deoxycorticosterone acetate-salt hypertension. J Vase Res 1994; 31: 48
- Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 1989; 13: 589–597
- Johnson M D, Grignolo A, Kuhn C M, Schanberg S M. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sciences 1983; 33: 169–180
- Thyberg J, Fredholm B B. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp Cell Res 1987; 170: 160–169
- Lever A F. Angiotensin II, angiotensin-converting enzyme iahibitors, and blood vessel structure. Am J Medicine 1992; 92(Suppl 4B)35S–38S
- Soltis E E. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. J Pnarmacol Exp Therap 1993; 266: 642–646